From theory to practice: the versatility of drug-coated balloons around the world
Sponsored by B. Braun
Stents, scaffolds and DCB
CTO
Symposium
B.Braun
Room 252B
Anchorperson: Pedro Lemos
Spokesperson: Bruno Scheller
Discussants: Victor Alfonso Jimenez Diaz, Antoinette Neylon
Watch this session if you want
- To learn more about the safety and effectiveness of the best-investigated coronary drug-coated balloons
- To learn how drug-coated balloons are used in a variety of settings around the world
- To gain confidence in using drug-coated balloon with a data-driven treatment choice
- To gain an understanding how drug-coated balloon can reduce complexity in today’s PCI
- To gain an understanding of the active drug-coated balloon coatings paclitaxel and sirolimus and their strength in various indications
- To receive the latest clinical insights into the available data for drug-coated balloon usage in de-novo lesions
- To learn about practical experiences on drug-coated balloon in large vessels, bifurcations, multivessel disease and CTO
- To get an understanding how to use the hybrid approach especially for challenging lesions to improve clinical outcome
Welcome and session objectives
Pedro Lemos
Where it all started – A journey to the origin of drug-coated balloon in Europe
Bruno Scheller
Pave the way in calcified lesions – Synergistic use of drug-coated balloon and intravascular lithotripsy
Pedro Lemos
Metall-free PCI in STEMI - Go or no go?
Antoinette Neylon
Deciphering sirolimus efficacy - An OCT approach to understand clinical device performance
Victor Alfonso Jimenez Diaz
The journey continues – From paclitaxel to sirolimus?
Bruno Scheller
Discussion and audience interaction
Session evaluation and key learnings
Bruno Scheller
